Protagonist Therapeutics PTGX
NASDAQ PTGX
$139.63 +0.44 (+0.32%)
As of: Oct 2, 2026 · 3:46 PM EDT

Protagonist Therapeutics (PTGX) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Protagonist Therapeutics (PTGX) reported Depreciation & Amortization (CF) of $397,000 for Q2 2026, up 30.6% from $304,000 a year earlier but down 2.5% from the prior quarter.

Analysis

Protagonist Therapeutics (PTGX) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Protagonist Therapeutics' Depreciation & Amortization (CF) came in at $1.54 million, up 72.8% year-over-year; for FY2025, it was $1.28 million, up 55.0% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $826,000 in FY2024 (-15.5%), $977,000 in FY2023 (-5.5%), $1.03 million in FY2022 (+27.2%) and $813,000 in FY2021 (-14.2%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $118,000 in Q4 2024 and a high of $407,000 in Q1 2026.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last six quarters, with growth averaging 43.2% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2025 (growth of 218.6%); the low point was Q4 2024 (a decline of 52.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $407,000 (Q1 2026), $376,000 (Q4 2025) and $361,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Protagonist Therapeutics 9.11 Bn 9.11 Bn - 397,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 397,000.00
Mar 31, 2026 407,000.00
Dec 31, 2025 376,000.00
Sep 30, 2025 361,000.00
Jun 30, 2025 304,000.00
Mar 31, 2025 239,000.00
Dec 31, 2024 118,000.00
Sep 30, 2024 231,000.00
Jun 30, 2024 241,000.00
Mar 31, 2024 236,000.00
Dec 31, 2023 248,000.00
Sep 30, 2023 244,000.00
Jun 30, 2023 237,000.00
Mar 31, 2023 248,000.00
Dec 31, 2022 256,000.00
Sep 30, 2022 270,000.00
Jun 30, 2022 259,000.00
Mar 31, 2022 249,000.00
Dec 31, 2021 235,000.00
Sep 30, 2021 213,000.00
API Access

Protagonist Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PTGX&period=max&api_key=YOUR_API_KEY